We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$224M
AUM Growth
+$26.5M
Cap. Flow
+$16.5M
Cap. Flow %
7.39%
Top 10 Hldgs %
27.71%
Holding
558
New
25
Increased
144
Reduced
58
Closed
2

Top Buys

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$1.38M
2
JPM icon
JPMorgan Chase
JPM
+$932K
3
TROW icon
T. Rowe Price
TROW
+$814K
4
JNJ icon
Johnson & Johnson
JNJ
+$659K
5
SCHW
Charles Schwab
SCHW
+$636K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$256K
2
BUD icon
AB InBev
BUD
+$191K
3
GE icon
GE Aerospace
GE
+$138K
4
GILD icon
Gilead Sciences
GILD
+$108K
5
INTC icon
Intel
INTC
+$72.9K

Sector Composition

Rank Sector Weight
1 Healthcare 17.74%
2 Technology 16.33%
3 Financials 12.83%
4 Industrials 8.85%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PNRG icon
176
PrimeEnergy Resources
PNRG
$298M
$206K 0.09%
2,233
– –
PLTR icon
177
Palantir
PLTR
$295B
$204K 0.09%
13,300
+900
+7% +$10.2K
NTR icon
178
Nutrien
NTR
$33.2B
$203K 0.09%
3,436
+1
+0% +$64
CPB icon
179
Campbell Soup
CPB
$6.55B
$203K 0.09%
4,437
+554
+14% +$28.6K
CLX icon
180
Clorox
CLX
$11.6B
$197K 0.09%
1,238
+800
+183% +$129K
WASH icon
181
Washington Trust Bancorp
WASH
$743M
$196K 0.09%
7,320
+4,745
+184% +$133K
BDX icon
182
Becton Dickinson
BDX
$45.6B
$192K 0.09%
728
-225
-24% -$57.1K
DD icon
183
DuPont de Nemours
DD
$18.5B
$192K 0.09%
2,140
+44
+2% +$3.78K
IHE icon
184
iShares US Pharmaceuticals ETF
IHE
$1.46B
$189K 0.08%
3,168
– –
CMCSA icon
185
Comcast
CMCSA
$85B
$189K 0.08%
4,544
+334
+8% +$13.3K
MRNA icon
186
Moderna
MRNA
$21.8B
$187K 0.08%
1,535
– –
PARA
187
DELISTED
Paramount Global Class B
PARA
$183K 0.08%
11,530
+400
+4% +$7.22K
INTU icon
188
Intuit
INTU
$86.5B
$183K 0.08%
400
– –
NEE icon
189
NextEra Energy
NEE
$181B
$178K 0.08%
2,400
– –
ADSK icon
190
Autodesk
ADSK
$49.5B
$174K 0.08%
850
– –
VGSH icon
191
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$173K 0.08%
3,000
+500
+20% +$29.1K
YUMC icon
192
Yum China
YUMC
$16.5B
$172K 0.08%
3,050
+1,400
+85% +$84.4K
VEA icon
193
Vanguard FTSE Developed Markets ETF
VEA
$229B
$168K 0.08%
3,642
+1,322
+57% +$60.8K
CCI icon
194
Crown Castle
CCI
$33.3B
$167K 0.07%
1,466
+165
+13% +$19.6K
LITE icon
195
Lumentum
LITE
$55.5B
$166K 0.07%
2,925
– –
SO icon
196
Southern Company
SO
$109B
$163K 0.07%
2,319
+5
+0.2% +$359
GIS icon
197
General Mills
GIS
$19.1B
$161K 0.07%
2,100
-200
-9% -$17.1K
GEN icon
198
Gen Digital
GEN
$16.4B
$160K 0.07%
8,600
– –
TY icon
199
TRI-Continental Corp
TY
$1.86B
$159K 0.07%
5,800
+325
+6% +$8.62K
AVY icon
200
Avery Dennison
AVY
$13B
$156K 0.07%
910
– –
6 7
8
9 10

Similar funds

JGCM
Joseph Group Capital Management Columbus, Ohio $400M AUM 18.42% 1-Year Est. Return
AIM
Alpine Investment Management Hong Kong $401M AUM 17.09% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return
MAG
Mokosak Advisory Group Urbandale, Iowa $399M AUM 16.58% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return
MM
Meridian Management Little Rock, Arkansas $402M AUM 17.05% 1-Year Est. Return

Brown, Lisle/Cummings's Q2 2023 Portfolio in Review

As of Q2 2023, Brown, Lisle/Cummings held 558 positions worth $224M, up 13% from $197M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $16.5M of net new capital in Q2 2023, opening 25 new positions and adding to 144 existing holdings. Its largest new stake was Charles Schwab: 12,150 shares worth $689K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $256K trimmed.

  • Brown, Lisle/Cummings's largest Q2 2023 buy was Charles Schwab: 12,150 shares worth $689K.
  • Brown, Lisle/Cummings added most to Canadian National Railway in Q2 2023, an estimated $1.38M increase.
  • Brown, Lisle/Cummings's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $256K.
  • Brown, Lisle/Cummings fully exited J.M. Smucker in Q2 2023, selling an estimated $15.7K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $224M portfolio in Q2 2023.
  • Brown, Lisle/Cummings opened 25 new positions and closed 2 in Q2 2023.
  • Brown, Lisle/Cummings's portfolio value rose 13% quarter-over-quarter to $224M.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2023, filed 1 Jul 2024.